HYPERTRIGLYCERIDEMIA
Clinical trials for HYPERTRIGLYCERIDEMIA explained in plain language.
Never miss a new study
Get alerted when new HYPERTRIGLYCERIDEMIA trials appear
Sign up with your email to follow new studies for HYPERTRIGLYCERIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo pill aims to lower dangerous blood fats
Disease control CompletedThis study tested a drug called Cipros 10 in 146 adults with high cholesterol and triglycerides. The goal was to see if it safely lowers blood fat levels. Participants took the medication or a placebo for a set period, and doctors measured changes in triglycerides and watched for…
Matched conditions: HYPERTRIGLYCERIDEMIA
Phase: PHASE3 • Sponsor: EMS • Aim: Disease control
Last updated May 26, 2026 07:48 UTC
-
Omega-3s tested for heart health in overweight chileans
Disease control CompletedThis study looked at whether omega-3 fatty acids can improve cholesterol levels and reduce inflammation in overweight or obese adults with high triglycerides. 40 participants in Chile took omega-3 supplements or a placebo in a crossover design. The goal was to see if a simple die…
Matched conditions: HYPERTRIGLYCERIDEMIA
Phase: NA • Sponsor: Universidad San Sebastián • Aim: Disease control
Last updated May 26, 2026 07:48 UTC
-
New drug targets dangerous fat levels in blood
Disease control CompletedThis early-stage study tested a new medicine called ARO-APOC3 in healthy people and those with extremely high triglycerides, including a rare genetic condition called familial chylomicronemia syndrome. The main goal was to check safety and how the drug moves through the body. 112…
Matched conditions: HYPERTRIGLYCERIDEMIA
Phase: PHASE1 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 07:35 UTC
-
New drug MAR001 targets high fat levels in blood
Disease control CompletedThis study tested a new drug called MAR001 in 55 adults with high triglycerides, a type of fat in the blood linked to metabolic problems. The main goal was to check if the drug is safe and tolerable. Researchers also looked at whether it lowers triglyceride levels. The study was …
Matched conditions: HYPERTRIGLYCERIDEMIA
Phase: PHASE1, PHASE2 • Sponsor: Marea Therapeutics • Aim: Disease control
Last updated May 26, 2026 07:27 UTC
-
New drug ARO-ANG3 tested for safety in high cholesterol patients
Disease control CompletedThis early-stage study tested a new drug called ARO-ANG3 in 93 healthy adults and patients with high cholesterol or high triglycerides. The main goal was to check safety and how the drug moves through the body. Researchers gave single or multiple doses to see if it could help con…
Matched conditions: HYPERTRIGLYCERIDEMIA
Phase: PHASE1 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 07:23 UTC
-
New drug shows promise for lowering dangerous fat levels in heart patients
Disease control CompletedThis study tested an experimental drug called olezarsen in 154 adults with high triglycerides (a type of fat in the blood) and either heart disease or very high triglycerides. The goal was to see if the drug could safely lower triglyceride levels more than a placebo over 6 and 12…
Matched conditions: HYPERTRIGLYCERIDEMIA
Phase: PHASE2 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New drug olezarsen shows promise in taming dangerous blood fats
Disease control CompletedThis study tested a new medicine called olezarsen in about 1,500 adults with very high triglycerides (a type of blood fat) and either heart disease or high risk for it. The goal was to see if olezarsen could lower triglyceride levels more than a placebo over 25 weeks. Participant…
Matched conditions: HYPERTRIGLYCERIDEMIA
Phase: PHASE3 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New cholesterol drug VSA003 tested for safety in healthy volunteers
Knowledge-focused CompletedThis early-phase study tested a single dose of VSA003 in 36 healthy Chinese adults with mildly high cholesterol or triglycerides. The main goal was to check safety and how the drug moves through the body, not to treat the condition. Participants were monitored for side effects an…
Matched conditions: HYPERTRIGLYCERIDEMIA
Phase: PHASE1 • Sponsor: Visirna Therapeutics HK Limited • Aim: Knowledge-focused
Last updated May 22, 2026 14:01 UTC